CIK 1278387
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Beverages | 41.41% | 1 |
| Health Care Equipment & Supplies | 21.25% | 1 |
| Machinery | 20.76% | 1 |
| Unclassified | 8.30% | 1 |
| Pharmaceuticals & Biotechnology | 8.28% | 2 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | MNST | Monster Beverage Corp | Consumer Staples | 41.41% |
| 2 | STAA | STAAR SURGICAL CO | Health Care | 21.25% |
| 3 | AXON | AXON ENTERPRISE, INC. | Industrials | 20.76% |
| 4 | IWM | ISHARES TR | Unclassified | 8.30% |
| 5 | LCTX | Lineage Cell Therapeutics, Inc. | Health Care | 5.52% |
| 6 | IMDX | Insight Molecular Diagnostics Inc. | Health Care | 2.76% |
5/6 names classified · sector 91.7% of weight · industry 91.7% · mkt cap 91.7%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 91.7% of the book is sector-classified (unclassified names shown, never dropped).
Only 21% of book weight classified — the grid is NOT representative of the whole book.
Classified: 20.8% of book weight (1/6 names) · unclassified 79.2%: MNST, STAA, IWM, LCTX, IMDX. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | MNSTMONSTER BEVERAGE CORP NEW | 8,107,796 | $587M | 41.4% | HOLD |
| 2 | STAASTAAR SURGICAL CO | 16,123,842 | $302M | 21.3% | ADD 7% |
| 3 | AXONAXON ENTERPRISE INC | 693,504 | $295M | 20.8% | HOLD |
| 4 | IWMISHARES TR | 474,920 | $118M | 8.3% | HOLD |
| 5 | LCTXLINEAGE CELL THERAPEUTICS IN | 49,560,992 | $78M | 5.5% | HOLD |
| 6 | IMDXINSIGHT MOLECULAR DIA INC | 11,931,839 | $39M | 2.8% | ADD 5% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| MNSTMONSTER BEVERAGE CORP NEW | 8.3M | 8.3M | 8.3M | 8.3M | 8.2M | 8.1M | $587M |
| STAASTAAR SURGICAL CO | 10.8M | 12.5M | 13.5M | 13.5M | 15.0M | 16.1M | $302M |
| AXONAXON ENTERPRISE INC | 722K | 696K | 694K | 694K | 694K | 694K | $295M |
| IWMISHARES TR | 520K | 475K | 475K | 475K | 475K | 475K | $118M |
| LCTXLINEAGE CELL THERAPEUTICS IN | 41.7M | 49.6M | 49.6M | 49.6M | 49.6M | 49.6M | $78M |
| IMDXINSIGHT MOLECULAR DIA INC | 6.2M | 11.4M | 11.4M | 11.4M | 11.4M | 11.9M | $39M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
